← Leaderboards
Maria Belen Cassera
Virginia Polytechnic Inst And St Univ
$4,454,225
Attributed
$7,664,803
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $831.9K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,664,803 · 3
By mechanism
R01$7,664,803 · 3
Top collaborators
- Paul R Carlier7 shared
- David G Kingston5 shared
- Michael Goetz3 shared
- Jason Anderson Clement2 shared
Most similar at Virginia Polytechnic Inst And St Univ
Same institution · by research overlap
- Paul R Carlier$6,583,641
- David G Kingston$12,925,812
- Michael Goetz$412,168
- Jason Anderson Clement$259,315
Others in their field
Top investigators on “Asexual”
- John C Boothroyd · Stanford University$14,343,749
- Guiyun Yan · University Of California-Irvine$13,748,338
- David Armand Fidock · Columbia University Health Sciences$13,540,041
- Jeffrey D Dvorin · Boston Children'S Hospital$11,443,717
- John Adams · University Of South Florida$11,069,810
- Stephen Lev Hoffman · Sanaria, Inc.$10,762,392
Research focus
AsexualMalariaProteomicsPlasmodium FalciparumPharmaceutical PreparationsDrug ResistanceAntimalarialsMetabolismMolecular TargetResistanceDoseAnalogArtemisininsChemistryLibrariesMammalian CellNovel TherapeuticsParasitesContractsLeadDrug CandidateLiverMedicalScreening
Grant awards (17)
Optimization of antimalarials targeting multiple life stages of the parasite$688,004
R01 · FY2025 · AI
Optimization of antimalarials targeting multiple life stages of the parasite$709,897
R01 · FY2024 · AI
Optimization of antimalarials targeting multiple life stages of the parasite$60,972
R01 · FY2024 · AI
Optimization of antimalarials targeting multiple life stages of the parasite$707,225
R01 · FY2023 · AI
Optimization of antimalarials targeting multiple life stages of the parasite$75,947
R01 · FY2023 · AI
Optimization of antimalarials targeting multiple life stages of the parasite$724,987
R01 · FY2022 · AI
Optimization of antimalarials targeting multiple life stages of the parasite$768,193
R01 · FY2021 · AI
Discovery and Mechanism of Antimalarial Natural Products$383,854
R01 · FY2018 · AT
Characterization of isoprenoid biosynthesis in human malaria gametocytes$375,000
R01 · FY2018 · AI · contact PI
Discovery and Mechanism of Antimalarial Natural Products$394,092
R01 · FY2017 · AT
Characterization of isoprenoid biosynthesis in human malaria gametocytes$375,000
R01 · FY2017 · AI · contact PI
Discovery and Mechanism of Antimalarial Natural Products$401,212
R01 · FY2016 · AT
Characterization of isoprenoid biosynthesis in human malaria gametocytes$375,000
R01 · FY2016 · AI · contact PI
Discovery and Mechanism of Antimalarial Natural Products$398,685
R01 · FY2015 · AT
Characterization of isoprenoid biosynthesis in human malaria gametocytes$394,848
R01 · FY2015 · AI · contact PI
Discovery and Mechanism of Antimalarial Natural Products$436,606
R01 · FY2014 · AT
Characterization of isoprenoid biosynthesis in human malaria gametocytes$395,281
R01 · FY2014 · AI · contact PI